correction 5 patients were enrolled in the THRD study before liver tox detected:
Five subjects were enrolled in the first cohort of two 200-mg doses a day, with the second and third participants showing raised levels of the liver enzymes alanine transaminase (ALT) and aspartate transaminase (AST) at their week eight study visits.